"Given this low level of market penetration, the current $125 million U.S. market could expand significantly upon the introduction of an easy-to-use presentation."
Does this mean that Biodel could end up ordering FAR more syringes than catered for by the supply agreement which is surely just for a base requirement?
new deal?, page-28
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)